→ French pharma Ipsen is going to be playing host to a coworking facility in Boston. Just weeks after announcing it was moving its US headquarters from New Jersey to Boston, Ipsen announced Thursday that its shiny new HQ will have shared “innovation” space. The pharma is teaming up with BioLabs, a network of biotech coworking spaces that has locations all over the country.
The shared laboratory space, called the Ipsen Innovation Center – BioLabs, will span 15,000 square-feet. It will include office and laboratory space to support entrepreneurs and startups. Ipsen is providing the space and some educational programs, mentoring and office hours with Ipsen R&D teams, while BioLabs is managing the operations. The space will open the first quarter of 2019, with BioLabs accepting applications for occupancy in the coming months.
“External innovation is core to Ipsen’s growth strategy and we are committed to supporting the biotech ecosystem that plays such a vital role in discovering innovative new therapies,” said Ivana Magovčević-Liebisch, EVP and chief business officer at Ipsen, in a statement. “Ipsen is excited to partner with BioLabs to establish a world-class co-working space that will provide a launchpad for the next generation of high-impact biotechs.”
→ In the latest NYC tactic to spur its biotech scene, the state has handed $25 million in funding to business accelerator IndieBio. The San Francisco-based group will be opening a space in New York City next year with the funds. IndieBio is looking to work with 20 startups a year and says it will provide each with up to $2 million in investment dollars (along with the usual accelerator mentorship). They’re looking for a 12,000 to 20,000 square-foot place, preferably in Manhattan near a major transportation hub. “There is a huge amount of talent that is untapped potential in New York,” founder Arvind Gupta told the Wall Street Journal. “Really the challenge will be galvanizing that ecosystem and having it believe there is a new way of starting bio-tech companies that can be lower cost, faster to market.” The state’s $25 million investment will come over five years and is part of a $620 million initiative to strengthen its life sciences research cluster.
→ The UK’s Domainex has opened up BD offices in Boston and San Diego.
The best place to read Endpoints News? In your inbox.
Comprehensive daily news report for those who discover, develop, and market drugs. Join 51,000+ biopharma pros who read Endpoints News by email every day.Free Subscription